{"id":"W2095707498","doi":"10.1136/jnnp-2013-307282","title":"Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial","year":2014,"lang":"en","type":"article","venue":"Journal of Neurology Neurosurgery & Psychiatry","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Bayer HealthCare; Celgene; Actelion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Pfizer; Sanofi; National Multiple Sclerosis Society","keywords":"Tolerability; Medicine; Placebo; Internal medicine; Adverse effect; Gastroenterology; Clinical endpoint; Anesthesia; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001796672,0.00151449,0.003243784,0.0003395367,0.0003301445,0.000748203,0.0007692163,0.001614246,0.00747869],"category_scores_gemma":[0.001403311,0.0005557241,0.001042663,0.0003730228,0.0008023749,0.0007166048,0.000293136,0.001637487,0.0009017444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004922494,"about_ca_system_score_gemma":0.00103773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006435994,"about_ca_topic_score_gemma":0.001265884,"domain_scores_codex":[0.9995756,0.0002263494,0.0000284251,0.00007174913,0.00003466056,0.00006324633],"domain_scores_gemma":[0.9994426,0.000157296,0.0001527399,0.00003546226,0.00003643353,0.0001754186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9610885,0.004714868,0.0003961165,0.001704658,0.0006499481,0.0001085181,0.00006659982,0.0002540897,0.006106955,0.0001092194,0.0008939855,0.02390653],"study_design_scores_gemma":[0.9633011,0.03476785,0.0008628739,0.00003263051,0.0001638821,0.00004103355,0.000007819613,0.0001329785,0.0001982852,0.00005080181,0.0004349109,0.000005847222],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790072,0.009516648,0.0008371751,0.0007757538,0.0005046992,0.005958428,0.001049311,0.0002170372,0.0021336],"genre_scores_gemma":[0.9673448,0.009702981,0.002592692,0.001823271,0.0008070309,0.0101872,0.001629047,0.0000427493,0.005870301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00747869,"threshold_uncertainty_score":0.02501869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02120946325481602,"score_gpt":0.2571644914723998,"score_spread":0.2359550282175838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}